LGVN is Longeveron Inc. (Healthcare) — a non-dividend-paying stock. Trading at $6.81. Market cap: $22M.
Stock snapshot
| Price | $6.81 |
| Market cap | $22M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About LGVN
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Related non-dividend companies
Other non-dividend stocks investors research alongside LGVN. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is LGVN's current stock price?
LGVN (Longeveron Inc.) is currently trading at $6.81.
Does LGVN pay a dividend?
LGVN (Longeveron Inc.) does not currently pay a regular dividend.
Track LGVN in DiviDrip
Add LGVN to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search LGVN and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.